NCT07544654 2026-05-27DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard ChemotherapyBoehringer IngelheimPhase 3 Not yet recruiting390 enrolled